Where chloroquine still works: The genetic make-up and susceptibility of Plasmodium vivax to chloroquine plus primaquine in Bhutan

Malaria Journal

Volumn 15, Issue 1, 2016, Pages

  Wangchuk, Sonam ^a   Drukpa, Tobgyel ^a   Penjor, Kinley ^b   Peldon, Tashi ^c   Dorjey, Yeshey ^d   Dorji, Kunzang ^a   Chhetri, Vishal ^c   Trimarsanto, Hidayat ^e,f,g   To, Sheren ^h   Murphy, Amanda ^h,i   Von Seidlein, Lorenz ^j,k   Price, Ric N ^h,k   Thriemer, Kamala ^h   Auburn, Sarah ^h  

^a Ministry of Health   (Bhutan)

^b Ministry of Health   (Bhutan)

^c Gelephu Regional Referral Hospital   (Bhutan)

^d Yebilaptsa Hospital   (Bhutan)

^e EIJKMAN INSTITUTE FOR MOLECULAR BIOLOGY   (Indonesia)

^f Ministry of Research and Technology (RISTEK)   (Indonesia)

^g AGENCY FOR THE ASSESSMENT AND APPLICATION OF TECHNOLOGY BPPT   (Indonesia)

^h MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

ⁱ UNIVERSITY OF QUEENSLAND   (Australia)

^j MAHIDOL UNIVERSITY   (Thailand)

^k UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

Bhutan; Chloroquine; Imported malaria; India; Malaria; Plasmodium vivax; Population genetics; Primaquine

Indexed keywords

CHLOROQUINE; PRIMAQUINE; ANTIMALARIAL AGENT;

ADULT; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; BHUTAN; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GENOTYPE; HEADACHE; HUMAN; MALE; MIDDLE AGED; NAUSEA; NONHUMAN; PARASITEMIA; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; ADOLESCENT; AGED; CLASSIFICATION; DRUG EFFECTS; FOLLOW UP; GENETICS; QUESTIONNAIRE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIMALARIALS; BHUTAN; CHLOROQUINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLASMODIUM VIVAX; PRIMAQUINE; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84971507025     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-016-1320-8     Document Type: Article

References (45)

1. Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, Temperley WH, et al. The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Neglect Trop Dis. 2010;4:e774. doi: 10.1371/journal.pntd.0000774.
2. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. Vivax malaria: neglected and not benign Am J Trop Med Hyg. 2007;77:79-87.
3. World Health Organization. World Malaria Report 2014. Geneva: World Health Organization; 2014.
4. Bousema T, Drakeley C. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev. 2011;24:377-410. doi: 10.1128/CMR.00051-10.
5. Gray KA, Dowd S, Bain L, Bobogare A, Wini L, Shanks GD, et al. Population genetics of Plasmodium falciparum and Plasmodium vivax and asymptomatic malaria in Temotu Province, Solomon Islands. Malar J. 2013;12:429. doi: 10.1186/1475-2875-12-429.
6. Jennison C, Arnott A, Tessier N, Tavul L, Koepfli C, Felger I, et al. Plasmodium vivax populations are more genetically diverse and less structured than sympatric Plasmodium falciparum populations. PLoS Neglect Trop Dis. 2015;9:e0003634. doi: 10.1371/journal.pntd.0003634.
7. Noviyanti R, Coutrier F, Utami RA, Trimarsanto H, Tirta YK, Trianty L, et al. Contrasting transmission dynamics of co-endemic Plasmodium vivax and P. falciparum: implications for malaria control and elimination. PLoS Neglect Trop Dis. 2015;9:e0003739. doi: 10.1371/journal.pntd.0003739.
8. Orjuela-Sanchez P, Sa JM, Brandi MC, Rodrigues PT, Bastos MS, Amaratunga C, et al. Higher microsatellite diversity in Plasmodium vivax than in sympatric Plasmodium falciparum populations in Pursat, Western Cambodia. Exp Parasitol. 2013;134:318-26. doi: 10.1016/j.exppara.2013.03.029.
9. Cheng Q, Cunningham J, Gatton ML. Systematic review of sub-microscopic P. vivax infections: prevalence and determining factors. PLoS Negl Trop Dis. 2015;9:e3413. doi: 10.1371/journal.pntd.0003413.
10. Yangzom T, Gueye CS, Namgay R, Galappaththy GN, Thimasarn K, Gosling R, et al. Malaria control in Bhutan: case study of a country embarking on elimination. Malar J. 2012;11:9. doi: 10.1186/1475-2875-11-9.
11. Ministry of Health Bhutan, WHO, The University of California SF. Eliminating malaria: case-study 9 climbing towards elimination in Bhutan. Geneva: World Health Organization; 2015.
12. Wangdi K, Gatton ML, Kelly GC, Clements AC. Cross-border malaria: a major obstacle for malaria elimination. Adv Parasitol. 2015;89:79-107. doi: 10.1016/bs.apar.2015.04.002.
13. Wangdi K, Kaewkungwal J, Singhasivanon P, Silawan T, Lawpoolsri S, White NJ. Spatio-temporal patterns of malaria infection in Bhutan: a country embarking on malaria elimination. Malar J. 2011;10:89. doi: 10.1186/1475-2875-10-89.
14. Barry AE, Waltmann A, Koepfli C, Barnadas C, Mueller I. Uncovering the transmission dynamics of Plasmodium vivax using population genetics. Pathog Glob Health. 2015;109:142-52. doi: 10.1179/2047773215Y.0000000012.
15. Price RN, von Seidlein L, Valecha N, Nosten F, Baird JK, White NJ. Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14:982-91. doi: 10.1016/S1473-3099(14)70855-2.
16. Butler T, Bell WR, Levin J, Linh NN, Arnold K. Typhoid fever. Studies of blood coagulation, bacteremia, and endotoxemia. Arch Int Med. 1978;138:407-10.
17. World Health Organization. Guidelines for the treatment of malaria. 3rd ed. Geneva: World Health Organization; 2015.
18. Padley D, Moody AH, Chiodini PL, Saldanha J. Use of a rapid, single-round, multiplex PCR to detect malarial parasites and identify the species present. Ann Trop Med Parasitol. 2003;97:131-7.
19. Karunaweera ND, Ferreira MU, Munasinghe A, Barnwell JW, Collins WE, King CL, et al. Extensive microsatellite diversity in the human malaria parasite Plasmodium vivax. Gene. 2008;410:105-12.
20. Koepfli C, Mueller I, Marfurt J, Goroti M, Sie A, Oa O, et al. Evaluation of Plasmodium vivax genotyping markers for molecular monitoring in clinical trials. J Infect Dis. 2009;199:1074-80.
21. Barkat A, Halim S, Poddar A, Badiuzzaman M, Osman A, ShanewazKhan M, et al. Socio-economic baseline survey of Chittagong Hill Tracts. Dhaka: United Nations Development Programme (UNDP); 2009.
22. Sutton PL. A call to arms: on refining Plasmodium vivax microsatellite marker panels for comparing global diversity. Malar J. 2013;12:447. doi: 10.1186/1475-2875-12-447.
23. Abdullah NR, Barber BE, William T, Norahmad NA, Satsu UR, Muniandy PK, et al. Plasmodium vivax population structure and transmission dynamics in Sabah Malaysia. PLoS One. 2013;8:e82553. doi: 10.1371/journal.pone.0082553.
24. Gunawardena S, Karunaweera ND, Ferreira MU, Phone-Kyaw M, Pollack RJ, Alifrangis M, et al. Geographic structure of Plasmodium vivax: microsatellite analysis of parasite populations from Sri Lanka, Myanmar, and Ethiopia. Am J Trop Med Hyg. 2010;82:235-42. doi: 10.4269/ajtmh.2010.09-0588.
25. Anderson TJ, Su XZ, Bockarie M, Lagog M, Day KP. Twelve microsatellite markers for characterization of Plasmodium falciparum from finger-prick blood samples. Parasitology. 1999;119(Pt 2):113-25.
26. Gatton ML, Cheng Q. Can estimates of antimalarial efficacy from field studies be improved? Trends Parasitol. 2008;24:68-73.
27. Haubold B, Hudson RR. LIAN, 3.0: detecting linkage disequilibrium in multilocus data. Linkage analysis. Bioinformatics. 2000;16:847-8.
28. Bowcock AM, Ruiz-Linares A, Tomfohrde J, Minch E, Kidd JR, Cavalli-Sforza LL. High resolution of human evolutionary trees with polymorphic microsatellites. Nature. 1994;368:455-7. doi: 10.1038/368455a0.
29. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987;4:406-25.
30. Paradis E, Claude J, Strimmer K. APE: analyses of phylogenetics and evolution in R language. Bioinformatics. 2004;20:289-90.
31. Dray S, Dufour AB. The ade4 package: implementing the duality diagram for ecologists. J Stat Softw. 2007;22:1-20.
32. Roy M, Bouma MJ, Ionides EL, Dhiman RC, Pascual M. The potential elimination of Plasmodium vivax malaria by relapse treatment: insights from a transmission model and surveillance data from NW India. PLoS Neglect Trop Dis. 2013;7:e1979. doi: 10.1371/journal.pntd.0001979.
33. White NJ. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011;10:297.
34. Grietens KP, Soto V, Erhart A, Ribera JM, Toomer E, Tenorio A, et al. Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon. Am J Trop Med Hyg. 2010;82:1017-23. doi: 10.4269/ajtmh.2010.09-0521.
35. Khantikul N, Butraporn P, Kim HS, Leemingsawat S, Tempongko MA, Suwonkerd W. Adherence to antimalarial drug therapy among vivax malaria patients in northern Thailand. J Health Popul Nutr. 2009;27:4-13.
36. Takeuchi R, Lawpoolsri S, Imwong M, Kobayashi J, Kaewkungwal J, Pukrittayakamee S, et al. Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border. Malar J. 2010;9:308. doi: 10.1186/1475-2875-9-308.
37. Ley B, Luter N, Espino FE, Devine A, Kalnoky M, Lubell Y, et al. The challenges of introducing routine G6PD testing into radical cure: a workshop report. Malar J. 2015;14:377. doi: 10.1186/s12936-015-0896-8.
38. Mukherjee MB, Colah RB, Martin S, Ghosh K. Glucose-6-phosphate dehydrogenase (G6PD) deficiency among tribal populations of India - Country scenario. Indian J Med Res. 2015;141:516-20.
39. Goyal M, Garg A, Goyal MB, Kumar S, Ramji S, Kapoor S. Newborn screening for G6PD deficiency: A 2-year data from North India. Indian J Public Health. 2015;59:145-8. doi: 10.4103/0019-557X.157537.
40. Koepfli C, Timinao L, Antao T, Barry AE, Siba P, Mueller I, et al. A large reservoir and little population structure in the South Pacific. PLoS One. 2013;8:e66041. doi: 10.1371/journal.pone.0066041.
41. Anderson TJ, Haubold B, Williams JT, Estrada-Franco JG, Richardson L, Mollinedo R, et al. Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Mol Biol Evol. 2000;17:1467-82.
42. Gunawardena S, Ferreira MU, Kapilananda GM, Wirth DF, Karunaweera ND. The Sri Lankan paradox: high genetic diversity in Plasmodium vivax populations despite decreasing levels of malaria transmission. Parasitology. 2014;141:880-90. doi: 10.1017/S0031182013002278.
43. Getachew S, To S, Trimarsanto H, Thriemer K, Clark TG, Petros B, et al. Variation in complexity of infection and transmission stability between neighbouring populations of Plasmodium vivax in Southern Ethiopia. PLoS One. 2015;10:e0140780. doi: 10.1371/journal.pone.0140780.
44. Liu Y, Auburn S, Cao J, Trimarsanto H, Zhou H, Gray KA, et al. Genetic diversity and population structure of Plasmodium vivax in Central China. Malar J. 2014;13:262. doi: 10.1186/1475-2875-13-262.
45. Maude RJ, Pontavornpinyo W, Saralamba S, Aguas R, Yeung S, Dondorp AM, et al. The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. Malar J. 2009;8:31. doi: 10.1186/1475-2875-8-31.